Drug intelligence / Profile preview

Jueyin Antihypertensive Decoction

Development stage: Unknown
Lead developer: Wuxi Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Jueyin Antihypertensive Decoction is a traditional Chinese medicine (TCM) formulation, specifically a modified version of the Chai-gui Decoction, developed by the Wuxi Hospital of Traditional Chinese Medicine. It is currently being investigated in a Phase 1 clinical trial for the treatment of Jueyin-type hypertension. The decoction is administered orally as an adjunct to standard antihypertensive therapy. Clinical evaluation focuses on its efficacy in reducing blood pressure and improving TCM syndrome scores, as well as its impact on mechanistic biomarkers including serum metabolites and vascular/endothelial markers.

Other names: Jueyin Antihypertensive DecoctionModified Chai-gui Decoction

Beyond the preview

Go deeper on Jueyin Antihypertensive Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jueyin Antihypertensive Decoction.

Explore the full profile